Skip to content
  • Members
  • Become a Member
Linkedin
  • About
    • What We Do
    • Member Directory
    • Board Members
  • Focus Areas
    • Access & Appropriate Use
    • Manufacturing
    • Research & Science
  • Resources
  • News
  • About
    • What We Do
    • Member Directory
    • Board Members
  • Focus Areas
    • Access & Appropriate Use
    • Manufacturing
    • Research & Science
  • Resources
  • News
Contact

Focus area: Access & Appropriate Use

MERCK KGaA MOBILE LAB DETECTS COUNTERFEIT MEDICINES WORLDWIDE

Mobidiag’s Fast Screening Test Identifies Resistant Bacteria, Assesses Patient Condition

Antibiotic Adjuvant’s Electronic Tool Reduces Antibiotic Misuse in the Long-Term Care Sector

Centrient and Cipla Combat Irrational Antibiotic Use in China and India

Sandoz Drives Remediation Program to Help Maintain Global Supplies of Critical Antibiotic

Pfizer Helps Deliver Medical Products by Drone in Ghana

BACT’ATTACK®

Pfizer, ICMR to Establish a Centre in New Delhi to Combat AMR

Abbott (formerly Alere) – Test Target Treat™

SIRTURO® (bedaquiline) Development and Launch

← Previous
Next →

The AMR Industry Alliance brings together biotech, diagnostics, generics and research-based pharmaceutical companies, to drive and measure industry progress to curb antimicrobial resistance.

  • Follow on LinkedIn

Featured

  • 2024 Year in Review
  • Manufacturing Standard
  • Access principles
  • Member companies

Explore

  • About
  • Focus Areas
  • Resources
  • News

Get involved

  • Become a Member
  • Contact
  • Media enquiries

© 2026 AMR Industry Alliance. All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Privacy Centre
  • Cookie Settings